Trials / Completed
CompletedNCT01022632
Effect of Curcumin as Nutraceutical in Patients of Depression
A Randomized, Active Controlled, Open Label, Parallel Group Study to Compare the Efficacy of Extract of Curcuma Longa (Turmeric) With Fluoxetine and to Study Its Effect as an Add on Therapy to Fluoxetine in Patients of Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Government Medical College, Bhavnagar · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find the effect of commonly used nutraceutical curcumin ( extract of Curcuma longa, commonly called 'Haldi' in Hindi) in patients of depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Curcumin | Curcumin 500 mg 12 hourly after taking food in morning and evening for 6 weeks |
| DRUG | Fluoxetine | Fluoxetine ; 20 mg Once a day in morning after taking food for 6 weeks |
| DIETARY_SUPPLEMENT | Curcumin and Fluoxetine | Curcumin 500 12 hourly after taking food in morning and evening and Fluoxetine 20 mg Once a day in morning after taking food for 6 weeks |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2009-12-01
- Last updated
- 2010-01-28
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01022632. Inclusion in this directory is not an endorsement.